Exact Mass: 606.3992

PA(10:0/19:0)

C32H63O8P (606.426)

PA(10:0/19:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(10:0/19:0), in particular, consists of one chain of capric acid at the C-1 position and one chain of nonadecylic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(15:0/14:0)

C32H63O8P (606.426)

PA(15:0/14:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(15:0/14:0), in particular, consists of one chain of pentadecanoic acid at the C-1 position and one chain of myristic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(21:0/8:0)

C32H63O8P (606.426)

PA(21:0/8:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(21:0/8:0), in particular, consists of one chain of heneicosylic acid at the C-1 position and one chain of caprylic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(8:0/21:0)

C32H63O8P (606.426)

PA(8:0/21:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(8:0/21:0), in particular, consists of one chain of caprylic acid at the C-1 position and one chain of heneicosylic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(10:0/i-19:0)

C32H63O8P (606.426)

PA(10:0/i-19:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(10:0/i-19:0), in particular, consists of one chain of capric acid at the C-1 position and one chain of isononadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(8:0/a-21:0)

C32H63O8P (606.426)

PA(8:0/a-21:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(8:0/a-21:0), in particular, consists of one chain of caprylic acid at the C-1 position and one chain of anteisoheneicosanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(8:0/i-21:0)

C32H63O8P (606.426)

PA(8:0/i-21:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(8:0/i-21:0), in particular, consists of one chain of caprylic acid at the C-1 position and one chain of isoheneicosanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(a-13:0/i-16:0)

C32H63O8P (606.426)

PA(a-13:0/i-16:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(a-13:0/i-16:0), in particular, consists of one chain of anteisotridecanoic acid at the C-1 position and one chain of isohexadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(a-21:0/8:0)

C32H63O8P (606.426)

PA(a-21:0/8:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(a-21:0/8:0), in particular, consists of one chain of anteisoheneicosanoic acid at the C-1 position and one chain of caprylic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(i-12:0/a-17:0)

C32H63O8P (606.426)

PA(i-12:0/a-17:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-12:0/a-17:0), in particular, consists of one chain of isododecanoic acid at the C-1 position and one chain of anteisoheptadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(i-12:0/i-17:0)

C32H63O8P (606.426)

PA(i-12:0/i-17:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-12:0/i-17:0), in particular, consists of one chain of isododecanoic acid at the C-1 position and one chain of isoheptadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(i-13:0/i-16:0)

C32H63O8P (606.426)

PA(i-13:0/i-16:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-13:0/i-16:0), in particular, consists of one chain of isotridecanoic acid at the C-1 position and one chain of isohexadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(i-14:0/a-15:0)

C32H63O8P (606.426)

PA(i-14:0/a-15:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-14:0/a-15:0), in particular, consists of one chain of isotetradecanoic acid at the C-1 position and one chain of anteisopentadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(i-14:0/i-15:0)

C32H63O8P (606.426)

PA(i-14:0/i-15:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-14:0/i-15:0), in particular, consists of one chain of isotetradecanoic acid at the C-1 position and one chain of isopentadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(i-21:0/8:0)

C32H63O8P (606.426)

PA(i-21:0/8:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-21:0/8:0), in particular, consists of one chain of isoheneicosanoic acid at the C-1 position and one chain of caprylic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

Tasidotin

C32H58N6O5 (606.4468)

DG(12:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0)

C35H58O8 (606.4131)

DG(12:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/12:0/0:0)

C35H58O8 (606.4131)

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(12:0/0:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15))

C35H58O8 (606.4131)

DG(12:0/0:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0/12:0)

C35H58O8 (606.4131)

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0)

C35H58O8 (606.4131)

DG(i-12:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/i-12:0/0:0)

C35H58O8 (606.4131)

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/0:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15))

C35H58O8 (606.4131)

DG(i-12:0/0:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0/i-12:0)

C35H58O8 (606.4131)

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

[7-acetyloxy-4,6-di(butanoyloxy)-8-hydroxy-3a,5a,9-trimethyl-1-propan-2-yl-1,2,3,4,5,6,7,8,10a,10b-decahydrocyclohepta[e]inden-2-yl] butanoate

C34H54O9 (606.3768)

Digonazole

C34H58N2O7 (606.4244)

MK 800-62F1

C35H58O8 (606.4131)

Rakicidin A

C32H54N4O7 (606.3992)

Lanceolitol A7

C31H58O11 (606.3979)

Fusapyrone

C34H54O9 (606.3768)

Agave-Saponin A

C34H54O9 (606.3768)

curculigosaponin B

C35H58O8 (606.4131)

prosapogenin

C35H58O8 (606.4131)

C39H58O5

C39H58O5 (606.4284)

schizonellin B

C30H54O12 (606.3615)

C30H54O12

C30H54O12 (606.3615)

C35H58O8

C35H58O8 (606.4131)

C32H54N4O7

C32H54N4O7 (606.3992)

(24S)-24-ethyl-cholesta-7,22E-diene-5alpha,6beta-diol 3-O-beta-D-glucoside|recurvoside B

C35H58O8 (606.4131)

gagunin F

C34H54O9 (606.3768)

alloxanthin 3-acetate

C42H54O3 (606.4073)

Dammarenediol II 3-O-caffeate

C39H58O5 (606.4284)

gagunin E

C34H54O9 (606.3768)

3-O-(alpha-L-Arabopyranosyl)-??

C35H58O8 (606.4131)

anthogorgiene M

C44H46O2 (606.3498)

7alpha-acetoxy-21R?,23R?-epoxy-1alpha,24S?,25-trihydroxy-21alpha-ethoxy-4,4,8-trimethyl-cholesta-14-en-3-one|brujavanone N

C34H54O9 (606.3768)

(2alpha,3beta,18beta)-23-O-(trans-p-coumaroyl)-19(18?17)-abeo-28-norolean-12-ene-2,3,18-triol|leonurusoleanolide G

C38H54O6 (606.392)

3-O-beta-D-glucopyranosyl-14-H-27-norolean-12-ene-3beta,28,29-triol

C35H58O8 (606.4131)

leonurusoleanolide B

C38H54O6 (606.392)

SCHEMBL17188496

C39H50N4O2 (606.3934)

(22E,24S)-3beta,25-dihydroxy-15alpha-O-beta-D-glucopyranosyl-ergosta-7,22-dien-6-one|fomentarol D

C34H54O9 (606.3768)

3-O-(beta-D-xylopyranosyl)-spergulagenin A

C35H58O8 (606.4131)

Elansolid B1

C37H50O7 (606.3556)

cyclosieversigenin 3-O-beta-D-xylopyranoside

C35H58O8 (606.4131)

3alpha-hydroxy-11alpha-(4-hydroxy-3-methoxy)benzoyloxybauer-1-one|ulmuestone

C38H54O6 (606.392)

Mirabimide B

C32H54N4O7 (606.3992)

1alpha,7alpha-diacetoxy-17alpha-20S-21,24-epoxy-apotirucall-14-ene-3alpha,23R,24S,25-tetraol

C34H54O9 (606.3768)

Roxaticin

C34H54O9 (606.3768)

rhabdastoside A

C35H58O8 (606.4131)

21alpha-hydroxyserrat-14-en-3beta-yl p-dihydrocaffeate|Phlegmanol A

C39H58O5 (606.4284)

16-Deoxybarringtogenol-C28-O-lyxosid

C35H58O8 (606.4131)

Pavoninin 3

C35H58O8 (606.4131)

NF00659B2

C38H54O6 (606.392)

Tyr Val Lys Ala Leu

C30H50N6O7 (606.3741)

Arg Tyr Ile Arg

C27H46N10O6 (606.3602)

Ile Arg Tyr Arg

C27H46N10O6 (606.3602)

3-[(2R,3S,4R,6R)-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]-4-hydroxy-6-[(4E,6E,9Z)-3-hydroxy-8-(hydroxymethyl)-2,6,10,12-tetramethyloctadeca-4,6,9-trien-2-yl]pyran-2-one

C34H54O9 (606.3768)

3-O-p-hydroxybenzoyl ceanothic acid

C37H50O7 (606.3556)

(3R,6R)-6-((3R,5R,7R,8R,9S,10S,12S,13R,14S,17R)-3,7-diacetoxy-12-hydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)heptane-1,3-diyl diacetate

C34H54O9 (606.3768)

(3R,6R)-6-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7-diacetoxy-12-hydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)heptane-1,3-diyl diacetate

C34H54O9 (606.3768)

Ile Arg Arg Tyr

C27H46N10O6 (606.3602)

Ile Tyr Arg Arg

C27H46N10O6 (606.3602)

Leu Arg Arg Tyr

C27H46N10O6 (606.3602)

Leu Arg Tyr Arg

C27H46N10O6 (606.3602)

Leu Tyr Arg Arg

C27H46N10O6 (606.3602)

Arg Ile Arg Tyr

C27H46N10O6 (606.3602)

Arg Ile Tyr Arg

C27H46N10O6 (606.3602)

Arg Leu Arg Tyr

C27H46N10O6 (606.3602)

Arg Leu Tyr Arg

C27H46N10O6 (606.3602)

Arg Arg Ile Tyr

C27H46N10O6 (606.3602)

Arg Arg Leu Tyr

C27H46N10O6 (606.3602)

Arg Arg Tyr Ile

C27H46N10O6 (606.3602)

Arg Arg Tyr Leu

C27H46N10O6 (606.3602)

Arg Tyr Leu Arg

C27H46N10O6 (606.3602)

Arg Tyr Arg Ile

C27H46N10O6 (606.3602)

Arg Tyr Arg Leu

C27H46N10O6 (606.3602)

Tyr Ile Arg Arg

C27H46N10O6 (606.3602)

Tyr Leu Arg Arg

C27H46N10O6 (606.3602)

Tyr Arg Ile Arg

C27H46N10O6 (606.3602)

Tyr Arg Leu Arg

C27H46N10O6 (606.3602)

Tyr Arg Arg Ile

C27H46N10O6 (606.3602)

Tyr Arg Arg Leu

C27H46N10O6 (606.3602)

PA(12:0/17:0)

C32H63O8P (606.426)

PA(13:0/16:0)

C32H63O8P (606.426)

PA(15:0/14:0)

C32H63O8P (606.426)

PA(16:0/13:0)

C32H63O8P (606.426)

PA(17:0/12:0)

C32H63O8P (606.426)

PA(14:0/15:0)

C32H63O8P (606.426)

PA 29:0

C32H63O8P (606.426)

OA-PA

C30H55O10P (606.3533)

Cucurbitacin C3

C34H54O9 (606.3768)

Fomentarol D

C34H54O9 (606.3768)

(1s,2s)-(+)-[1,2-cyclohexanediamino-n n-bis(3,5-di-t-butylsalicylidene)]aluminum (iii) chloride

C36H52AlClN2O2 (606.3533)

(1R,2R)-(-)-[1,2-Cyclohexanediamino-N,N-bis-(3,5-di-tert-butylsalicylidene)]aluminum(III)chloride

C36H52AlClN2O2 (606.3533)

(S,S)-N,N-bis-(3,5-Di-tert-butylsalicylidene)-1,2-cyclohexanediaminoaluminum chloride

C36H52AlClN2O2 (606.3533)

(S)-2-[[(1R,2R)-2-[[[3,5-Bis(tert-butyl)-2-hydroxyphenyl]methylene]amino]cyclohexyl]thioureido]-N-benzyl-N,3,3-trimethylbutanamide

C36H54N4O2S (606.3967)

Dmmpa

C32H63O8P (606.426)

DG(12:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0)

C35H58O8 (606.4131)

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/12:0/0:0)

C35H58O8 (606.4131)

DG(12:0/0:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15))

C35H58O8 (606.4131)

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0/12:0)

C35H58O8 (606.4131)

DG(i-12:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0)

C35H58O8 (606.4131)

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/i-12:0/0:0)

C35H58O8 (606.4131)

DG(i-12:0/0:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15))

C35H58O8 (606.4131)

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0/i-12:0)

C35H58O8 (606.4131)

CID 54715467

C38H54O6 (606.392)

(2S)-2-[(3S,9E,14S)-7,14-Dimethyl-11-methylidene-15-[(2R)-14-methylpentadecan-2-yl]-2,5,8,13-tetraoxo-1-oxa-4,7,12-triazacyclopentadec-9-en-3-yl]-2-hydroxyacetamide

C32H54N4O7 (606.3992)

Fusahexin

C30H50N6O7 (606.3741)

(3R,6R)-6-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7-diacetoxy-12-hydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)heptane-1,3-diyl diacetate

C34H54O9 (606.3768)

WURCS=2.0/1,1,0/[hx12xh_3-6_1*OCCOCCCCCCCCCCCCCCCCCC/6=O_2*OCCO_4*OCCO_5*OCCO]/1

C32H62O10 (606.4343)

CID 54710122

C34H54O9 (606.3768)

NAGlySer 11:0/18:3

C34H58N2O7 (606.4244)

NAGlySer 16:2/13:1

C34H58N2O7 (606.4244)

NAGlySer 13:1/16:2

C34H58N2O7 (606.4244)

NAGlySer 18:3/11:0

C34H58N2O7 (606.4244)

NAGlySer 13:0/16:3

C34H58N2O7 (606.4244)

NAGlySer 16:3/13:0

C34H58N2O7 (606.4244)

2,3-dihydroxypropyl [3-[(15Z,18Z)-hexacosa-15,18-dienoxy]-2-hydroxypropyl] hydrogen phosphate

C32H63O8P (606.426)

Mgdg O-22:6_3:0

C34H54O9 (606.3768)

PE-Cer 15:3;2O/16:4

C33H55N2O6P (606.3798)

PE-Cer 13:2;2O/18:5

C33H55N2O6P (606.3798)

PE-Cer 15:1;2O/14:0;O

C31H63N2O7P (606.4373)

PE-Cer 16:0;2O/13:1;O

C31H63N2O7P (606.4373)

PE-Cer 15:0;2O/14:1;O

C31H63N2O7P (606.4373)

PE-Cer 12:1;2O/17:0;O

C31H63N2O7P (606.4373)

PE-Cer 13:0;2O/16:1;O

C31H63N2O7P (606.4373)

PE-Cer 13:1;2O/16:0;O

C31H63N2O7P (606.4373)

PE-Cer 17:0;2O/12:1;O

C31H63N2O7P (606.4373)

PE-Cer 16:1;2O/13:0;O

C31H63N2O7P (606.4373)

PE-Cer 17:1;2O/12:0;O

C31H63N2O7P (606.4373)

PE-Cer 14:0;2O/15:1;O

C31H63N2O7P (606.4373)

PE-Cer 14:1;2O/15:0;O

C31H63N2O7P (606.4373)

PEtOH 12:0_15:0

C32H63O8P (606.426)

PMeOH 12:0_16:0

C32H63O8P (606.426)

PMeOH 13:0_15:0

C32H63O8P (606.426)

PEtOH 13:0_14:0

C32H63O8P (606.426)

[1-[(2-heptanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate

C30H55O10P (606.3533)

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-octanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate

C30H55O10P (606.3533)

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-pentanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (9Z,12Z)-nonadeca-9,12-dienoate

C30H55O10P (606.3533)

[1-[(2-butanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (11Z,14Z)-icosa-11,14-dienoate

C30H55O10P (606.3533)

[1-[(2-acetyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (13Z,16Z)-docosa-13,16-dienoate

C30H55O10P (606.3533)

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-propanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (11Z,14Z)-henicosa-11,14-dienoate

C30H55O10P (606.3533)

[1-[(2-hexanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate

C30H55O10P (606.3533)

(1-Acetyloxy-3-phosphonooxypropan-2-yl) heptacosanoate

C32H63O8P (606.426)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-heptanoyloxypropan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate

C30H55O10P (606.3533)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-octanoyloxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate

C30H55O10P (606.3533)

[1-butanoyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (11Z,14Z)-icosa-11,14-dienoate

C30H55O10P (606.3533)

(1-Hexanoyloxy-3-phosphonooxypropan-2-yl) tricosanoate

C32H63O8P (606.426)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexanoyloxypropan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate

C30H55O10P (606.3533)

(1-Butanoyloxy-3-phosphonooxypropan-2-yl) pentacosanoate

C32H63O8P (606.426)

(1-Nonanoyloxy-3-phosphonooxypropan-2-yl) icosanoate

C32H63O8P (606.426)

(1-Heptanoyloxy-3-phosphonooxypropan-2-yl) docosanoate

C32H63O8P (606.426)

(1-Octanoyloxy-3-phosphonooxypropan-2-yl) henicosanoate

C32H63O8P (606.426)

(1-Phosphonooxy-3-propanoyloxypropan-2-yl) hexacosanoate

C32H63O8P (606.426)

(1-Pentanoyloxy-3-phosphonooxypropan-2-yl) tetracosanoate

C32H63O8P (606.426)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] (11Z,14Z)-henicosa-11,14-dienoate

C30H55O10P (606.3533)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] (9Z,12Z)-nonadeca-9,12-dienoate

C30H55O10P (606.3533)

[1-acetyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (13Z,16Z)-docosa-13,16-dienoate

C30H55O10P (606.3533)

(1-Dodecanoyloxy-3-phosphonooxypropan-2-yl) heptadecanoate

C32H63O8P (606.426)

(1-Phosphonooxy-3-tridecanoyloxypropan-2-yl) hexadecanoate

C32H63O8P (606.426)

(1-Phosphonooxy-3-tetradecanoyloxypropan-2-yl) pentadecanoate

C32H63O8P (606.426)

(1-Phosphonooxy-3-undecanoyloxypropan-2-yl) octadecanoate

C32H63O8P (606.426)

[3-hydroxy-2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxypropyl] (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

C39H58O5 (606.4284)

(1-Decanoyloxy-3-phosphonooxypropan-2-yl) nonadecanoate

C32H63O8P (606.426)

(3R,6R)-6-((3R,5R,7R,8R,9S,10S,12S,13R,14S,17R)-3,7-diacetoxy-12-hydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)heptane-1,3-diyl diacetate

C34H54O9 (606.3768)

[(2R)-3-phosphonooxy-2-undecanoyloxypropyl] octadecanoate

C32H63O8P (606.426)

[(2R)-1-phosphonooxy-3-undecanoyloxypropan-2-yl] octadecanoate

C32H63O8P (606.426)

[1-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-hydroxypropan-2-yl] (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate

C39H58O5 (606.4284)

[1-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-hydroxypropan-2-yl] (5E,8E,11E,14E)-icosa-5,8,11,14-tetraenoate

C39H58O5 (606.4284)

[1-carboxy-3-[2-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxy-3-[(E)-undec-4-enoyl]oxypropoxy]propyl]-trimethylazanium

C35H60NO7+ (606.437)

[1-carboxy-3-[2-[(E)-dec-4-enoyl]oxy-3-[(6E,9E,12E)-pentadeca-6,9,12-trienoyl]oxypropoxy]propyl]-trimethylazanium

C35H60NO7+ (606.437)

[1-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-hydroxypropan-2-yl] (5E,8E,11E,14E,17E)-icosa-5,8,11,14,17-pentaenoate

C39H58O5 (606.4284)

[1-carboxy-3-[3-[(4E,7E)-deca-4,7-dienoyl]oxy-2-[(9E,12E)-pentadeca-9,12-dienoyl]oxypropoxy]propyl]-trimethylazanium

C35H60NO7+ (606.437)

[1-carboxy-3-[3-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-2-[(E)-tridec-8-enoyl]oxypropoxy]propyl]-trimethylazanium

C35H60NO7+ (606.437)

[1-carboxy-3-[2-[(4E,7E)-deca-4,7-dienoyl]oxy-3-[(9E,12E)-pentadeca-9,12-dienoyl]oxypropoxy]propyl]-trimethylazanium

C35H60NO7+ (606.437)

[(2R)-2-decanoyloxy-3-phosphonooxypropyl] nonadecanoate

C32H63O8P (606.426)

[1-carboxy-3-[3-[(E)-dec-4-enoyl]oxy-2-[(6E,9E,12E)-pentadeca-6,9,12-trienoyl]oxypropoxy]propyl]-trimethylazanium

C35H60NO7+ (606.437)

[1-carboxy-3-[3-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxy-2-[(E)-undec-4-enoyl]oxypropoxy]propyl]-trimethylazanium

C35H60NO7+ (606.437)

[1-carboxy-3-[2-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-3-[(E)-tridec-8-enoyl]oxypropoxy]propyl]-trimethylazanium

C35H60NO7+ (606.437)

[1-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxy-3-hydroxypropan-2-yl] (7E,9E,11E,13E,15E,17E)-icosa-7,9,11,13,15,17-hexaenoate

C39H58O5 (606.4284)

2-[[3-decanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C31H61NO8P+ (606.4135)

[1-carboxy-3-[2-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]oxy-3-pentanoyloxypropoxy]propyl]-trimethylazanium

C35H60NO7+ (606.437)

[1-carboxy-3-[3-heptanoyloxy-2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxypropoxy]propyl]-trimethylazanium

C35H60NO7+ (606.437)

2-[hydroxy-[2-[(Z)-icos-11-enoyl]oxy-3-propanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C31H61NO8P+ (606.4135)

2-[[3-heptanoyloxy-2-[(Z)-hexadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C31H61NO8P+ (606.4135)

2-[hydroxy-[3-octanoyloxy-2-[(Z)-pentadec-9-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C31H61NO8P+ (606.4135)

2-[hydroxy-[3-nonanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C31H61NO8P+ (606.4135)

2-[[3-acetyloxy-2-[(Z)-henicos-11-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C31H61NO8P+ (606.4135)

2-[hydroxy-[2-[(Z)-octadec-9-enoyl]oxy-3-pentanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C31H61NO8P+ (606.4135)

[1-carboxy-3-[2-[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]oxy-3-propanoyloxypropoxy]propyl]-trimethylazanium

C35H60NO7+ (606.437)

2-[[3-butanoyloxy-2-[(Z)-nonadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C31H61NO8P+ (606.4135)

2-[[2-[(Z)-heptadec-9-enoyl]oxy-3-hexanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C31H61NO8P+ (606.4135)

[1-carboxy-3-[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-nonanoyloxypropoxy]propyl]-trimethylazanium

C35H60NO7+ (606.437)

1-pentadecanoyl-2-tetradecanoyl-glycero-3-phosphate

C32H63O8P (606.426)

1-dodecanoyl-2-heptadecanoyl-glycero-3-phosphate

C32H63O8P (606.426)

1-hexadecanoyl-2-tridecanoyl-glycero-3-phosphate

C32H63O8P (606.426)

1-heptadecanoyl-2-lauroyl-sn-glycero-3-phosphate

C32H63O8P (606.426)

A 1,2-diacyl-sn-glycerol 3-phosphate in which the phosphatidyl acyl groups at postions 1 and 2 are specified as heptadecanoyl and lauroyl respectively.

1-tetradecanoyl-2-pentadecanoyl-glycero-3-phosphate

C32H63O8P (606.426)

1-tridecanoyl-2-hexadecanoyl-glycero-3-phosphate

C32H63O8P (606.426)

MGDG O-23:0;O

C32H62O10 (606.4343)

MGDG O-25:6

C34H54O9 (606.3768)

MGMG 25:6

C34H54O9 (606.3768)

DGGA 21:0;O

C30H54O12 (606.3615)

PA O-16:0/11:3;O3

C30H55O10P (606.3533)

PA O-16:0/12:2;O2

C31H59O9P (606.3896)

PA O-20:0/7:3;O3

C30H55O10P (606.3533)

PA O-20:0/8:2;O2

C31H59O9P (606.3896)

PA O-20:0/9:1;O

C32H63O8P (606.426)

PA O-27:3;O3

C30H55O10P (606.3533)

PA O-28:2;O2

C31H59O9P (606.3896)

PA O-29:1;O

C32H63O8P (606.426)

PA P-20:0/7:2;O3

C30H55O10P (606.3533)

PA P-20:0/8:1;O2

C31H59O9P (606.3896)

PA 18:1/9:1;O2

C30H55O10P (606.3533)

PA 20:0/7:2;O2

C30H55O10P (606.3533)

PA 20:0/8:1;O

C31H59O9P (606.3896)

PA 22:1/5:1;O2

C30H55O10P (606.3533)

PA 28:1;O

C31H59O9P (606.3896)

PA 10:0_19:0

C32H63O8P (606.426)

PA 11:0_18:0

C32H63O8P (606.426)

PA 12:0_17:0

C32H63O8P (606.426)

PA 13:0_16:0

C32H63O8P (606.426)

PA 14:0_15:0

C32H63O8P (606.426)

PA 25:0/4:0

C32H63O8P (606.426)

PA 27:0/2:0

C32H63O8P (606.426)

PG O-16:0/8:3;O

C30H55O10P (606.3533)

PG O-24:3;O

C30H55O10P (606.3533)

PG P-16:1/8:1;O

C30H55O10P (606.3533)

PG P-18:0/6:2;O

C30H55O10P (606.3533)

PG P-20:1/4:1;O

C30H55O10P (606.3533)

PG 20:1/4:1

C30H55O10P (606.3533)

PG 2:0_22:2

C30H55O10P (606.3533)

PG 20:2/4:0

C30H55O10P (606.3533)

PG 22:2/2:0

C30H55O10P (606.3533)

PG 24:2

C30H55O10P (606.3533)

LPEth 29:7

C34H55O7P (606.3685)

LPM 30:7

C34H55O7P (606.3685)

PEth 26:1;O

C31H59O9P (606.3896)

PEth 27:0

C32H63O8P (606.426)

PM 27:1;O

C31H59O9P (606.3896)

PM 28:0

C32H63O8P (606.426)

CerPE 14:1;O2/15:0;O

C31H63N2O7P (606.4373)

CerPE 15:1;O2/14:0;O

C31H63N2O7P (606.4373)

CerPE 16:1;O2/13:0;O

C31H63N2O7P (606.4373)

CerPE 17:1;O2/12:0;O

C31H63N2O7P (606.4373)

CerPE 18:1;O2/11:0;O

C31H63N2O7P (606.4373)

CerPE 19:1;O2/10:0;O

C31H63N2O7P (606.4373)

CerPE 29:1;O2;O

C31H63N2O7P (606.4373)

SM 14:1;O2/12:0;O

C31H63N2O7P (606.4373)

SM 15:1;O2/11:0;O

C31H63N2O7P (606.4373)

SM 16:1;O2/10:0;O

C31H63N2O7P (606.4373)

SM 26:1;O2;O

C31H63N2O7P (606.4373)

ST 28:2;O3;GlcA

C34H54O9 (606.3768)

ST 29:1;O2;GlcA

C35H58O8 (606.4131)

ST 29:2;O3;Hex

C35H58O8 (606.4131)

2-{[3,10-dihydroxy-9-(hydroxymethyl)-2,2,4a,6a,6b,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicen-4-yl]oxy}oxane-3,4,5-triol

C35H58O8 (606.4131)

(2s,3s)-2-{[(2s)-2-(dimethylamino)-4-methylpentanoyl]oxy}-n-[(2s)-1-[(2s)-2-[(2s)-2-isopropyl-3-methoxy-5-oxo-2h-pyrrole-1-carbonyl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]-3-methylpentanimidic acid

C32H54N4O7 (606.3992)

(1r,3ar,3br,5as,9ar,9bs,11as)-1-[(2s)-2-hydroxy-6-methylhept-5-en-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl 3-(3,4-dihydroxyphenyl)prop-2-enoate

C39H58O5 (606.4284)

6-{6,18-dihydroxy-7,7,12,16-tetramethyl-14-[(3,4,5-trihydroxyoxan-2-yl)oxy]pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-15-yl}-2-methylheptan-3-one

C35H58O8 (606.4131)

(1r)-4-[(3e,5e,7e,9e,11e,13e,15e)-18-[(4r)-4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl]-3,7,12,16-tetramethyloctadeca-3,5,7,9,11,13,15-heptaen-1,17-diyn-1-yl]-3,5,5-trimethylcyclohex-3-en-1-yl acetate

C42H54O3 (606.4073)

(2r,3r,4s,5s,6r)-2-{[(1r,3ar,5r,5ar,7s,9ar,9bs,11ar)-1-[(2r,3e,5r)-5-ethyl-6-methylhept-3-en-2-yl]-5,5a-dihydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,5h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H58O8 (606.4131)

(3z,5e,7r,8s,9s,11e,13e,15s,16r)-8-hydroxy-16-[(2s,3r,4s)-3-hydroxy-4-[(2r,5s,6r)-2-hydroxy-6-isopropyl-5-methyloxan-2-yl]pentan-2-yl]-3,15-dimethoxy-5,7,9,11-tetramethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one

C35H58O8 (606.4131)

(1s,2r,4as,4br,6ar,7r,8r,9r,10ar,10br)-1,8,9-trihydroxy-4',4',4a,4b,7,10a-hexamethyl-3,4,5,6,6a,8,9,10,10b,11-decahydro-1h-spiro[chrysene-2,1'-cyclopentan]-7-ylmethyl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

C38H54O6 (606.392)

2-{[2-(dimethylamino)-4-methylpentanoyl]oxy}-n-{1-[2-(2-isopropyl-3-methoxy-5-oxo-2h-pyrrole-1-carbonyl)pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl}-3-methylpentanimidic acid

C32H54N4O7 (606.3992)

(1r,3s,3ar,5as,7s,9ar,9br,11ar)-7-hydroxy-1-[(2r,3e,5s)-6-hydroxy-5,6-dimethylhept-3-en-2-yl]-9a,11a-dimethyl-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3ah,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one

C34H54O9 (606.3768)

(2r,3s,4s,5r,6r)-3-(acetyloxy)-6-[(acetyloxy)methyl]-5-hydroxy-2-[(2r,3s)-2,3,4-trihydroxybutoxy]oxan-4-yl hexadecanoate

C30H54O12 (606.3615)

19-hydroxy-3,7,7,11,16,20,20-heptamethylpentacyclo[13.8.0.0³,¹².0⁶,¹¹.0¹⁶,²¹]tricos-1(23)-en-8-yl 3-(3,4-dihydroxyphenyl)propanoate

C39H58O5 (606.4284)

(3r,4r,4ar,6as,6br,8ar,10s,12ar,12br,14bs)-4a-({[(2r,3s,4r,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-3,4,10-triol

C35H58O8 (606.4131)

(1r,2s,3ar,4s,5ar,6s,7s,8s,10as,10br)-7-(acetyloxy)-4,6-bis(butanoyloxy)-8-hydroxy-1-isopropyl-3a,5a,9-trimethyl-1h,2h,3h,4h,5h,6h,7h,8h,10ah,10bh-cyclohepta[e]inden-2-yl butanoate

C34H54O9 (606.3768)

(1s,2r,4ar,6as,8as,10r,12as,12bs,13r,14as,14br)-10-hydroxy-1,2,4a,6a,9,9,12a,14a-octamethyl-12-oxo-1,2,3,4,5,6,8,8a,10,11,12b,13,14,14b-tetradecahydropicen-13-yl 4-hydroxy-3-methoxybenzoate

C38H54O6 (606.392)

(1s,3ar,3br,5as,7s,9ar,9br,11ar)-1-[(2s,5e)-2,7-dihydroxy-6-methylhept-5-en-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

C39H58O5 (606.4284)

3-[(2r,3r,4r,6r)-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]-6-[(3s,4e,6e,8s)-8-[(1z,4r)-2,4-dimethyldec-1-en-1-yl]-3,9-dihydroxy-2,6-dimethylnona-4,6-dien-2-yl]-2-hydroxypyran-4-one

C34H54O9 (606.3768)

(2s,3s)-2-{[(2s)-2-(dimethylamino)-4-methylpentanoyl]oxy}-n-[(2s)-1-[(2r)-2-[(2r)-2-isopropyl-3-methoxy-5-oxo-2h-pyrrole-1-carbonyl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]-3-methylpentanimidic acid

C32H54N4O7 (606.3992)

3-[(2s,3s,4r,6r)-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]-6-[(4e,6e)-8-[(1z)-2,4-dimethyldec-1-en-1-yl]-3,9-dihydroxy-2,6-dimethylnona-4,6-dien-2-yl]-4-hydroxypyran-2-one

C34H54O9 (606.3768)

(2e,6e,10e,12r,14e)-12-hydroxy-17-[(1s,3s,6s)-6-hydroxy-2,2,6-trimethyl-3-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}cyclohexyl]-2,6,10,15-tetramethylheptadeca-2,6,10,14-tetraenal

C35H58O8 (606.4131)

3-(acetyloxy)-2-(hydroxymethyl)-5-[(2-methylpropanoyl)oxy]-6-(2,3,4-trihydroxybutoxy)oxan-4-yl tetradecanoate

C30H54O12 (606.3615)

(6r)-6-[(1r,3r,6s,8r,11s,12s,14s,15r,16r,18r)-6,18-dihydroxy-7,7,12,16-tetramethyl-14-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-15-yl]-2-methylheptan-3-one

C35H58O8 (606.4131)

4,5-dihydroxy-6-(hydroxymethyl)-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl octadec-11-enoate

C30H54O12 (606.3615)

(1s)-1-{[(2s)-1-[(2r)-2-[(2r)-2-isopropyl-3-methoxy-5-oxo-2h-pyrrole-1-carbonyl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl](methyl)carbamoyl}-2-methylpropyl (2s)-2-(dimethylamino)-4-methylpentanoate

C32H54N4O7 (606.3992)

10-hydroxy-1,2,4a,6a,9,9,12a,14a-octamethyl-12-oxo-1,2,3,4,5,6,8,8a,10,11,12b,13,14,14b-tetradecahydropicen-13-yl 4-hydroxy-3-methoxybenzoate

C38H54O6 (606.392)

7,9-dihydroxy-15-{1-hydroxy-4-[hydroxy(4-hydroxyphenyl)methyl]-1,3,3,6-tetramethyl-3a,4,5,7a-tetrahydro-2h-inden-5-yl}-4,8-dimethylpentadeca-2,4,10,12,14-pentaenoic acid

C37H50O7 (606.3556)

2-[15-(hexadecan-2-yl)-5,13-dihydroxy-7,14-dimethyl-11-methylidene-2,8-dioxo-1-oxa-4,7,12-triazacyclopentadeca-4,9,12-trien-3-yl]-2-hydroxyethanimidic acid

C32H54N4O7 (606.3992)

8-hydroxy-16-[3-hydroxy-4-(2-hydroxy-6-isopropyl-5-methyloxan-2-yl)pentan-2-yl]-3,15-dimethoxy-5,7,9,11-tetramethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one

C35H58O8 (606.4131)

(6r)-6-[(1s,3s,6s,8r,11s,12s,14s,15r,16r,18r)-6,18-dihydroxy-7,7,12,16-tetramethyl-14-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-15-yl]-2-methylheptan-3-one

C35H58O8 (606.4131)

2-{2-[(2-{[1,2-dihydroxy-3-(methylamino)decylidene]amino}-1-hydroxy-3-methylbutylidene)amino]-n,4-dimethylpentanamido}-3-(4-hydroxyphenyl)propanoic acid

C32H54N4O7 (606.3992)

4-[18-(4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl)-3,7,12,16-tetramethyloctadeca-3,5,7,9,11,13,15-heptaen-1,17-diyn-1-yl]-3,5,5-trimethylcyclohex-3-en-1-yl acetate

C42H54O3 (606.4073)

2-(2-{2-[(3-amino-1,2-dihydroxydecylidene)amino]-n,3-dimethylbutanamido}-n,4-dimethylpentanamido)-3-(4-hydroxyphenyl)propanoic acid

C32H54N4O7 (606.3992)

(1s,2r,4as,4br,6ar,7r,8r,9r,10ar,10br)-1,8,9-trihydroxy-4',4',4a,4b,7,10a-hexamethyl-3,4,5,6,6a,8,9,10,10b,11-decahydro-1h-spiro[chrysene-2,1'-cyclopentan]-7-ylmethyl 3-(4-hydroxyphenyl)prop-2-enoate

C38H54O6 (606.392)

(3z,5z,7z,9z,11z,13s,14r,16r,18r,22s,24r,26r,27z,29s,30s)-14,16,18,20,22,24,26-heptahydroxy-30-isopropyl-13,29-dimethyl-1-oxacyclotriaconta-3,5,7,9,11,27-hexaen-2-one

C34H54O9 (606.3768)

(2r,3r,4s,5s,6r)-3-(acetyloxy)-2-(hydroxymethyl)-5-[(2-methylpropanoyl)oxy]-6-[(2r,3s)-2,3,4-trihydroxybutoxy]oxan-4-yl tetradecanoate

C30H54O12 (606.3615)

7-hydroxy-1-(6-hydroxy-5,6-dimethylhept-3-en-2-yl)-9a,11a-dimethyl-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3ah,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one

C34H54O9 (606.3768)

2-[10,12-dihydroxy-14-(hydroxymethyl)-3,10-dimethyltricyclo[9.3.0.0³,⁷]tetradec-7-en-6-yl]propyl 2-[2-hydroxy-3,5-dimethyl-6-(3-oxopentan-2-yl)oxan-2-yl]propanoate

C35H58O8 (606.4131)

n-[(2r,3e)-4-[(9r,10r,14ar,16ar,17s,19s,20ar,20br)-17-(c-hydroxycarbonimidoyloxy)-19-methoxy-3,10,13,20b-tetramethyl-7-oxo-9h,10h,14ah,16ah,17h,18h,19h,20h,20ah-naphtho[2,1-h]oxacyclohexadecan-9-yl]pent-3-en-2-yl]ethanimidic acid

C36H50N2O6 (606.3669)

4a-({[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-3,4,10-triol

C35H58O8 (606.4131)

(9e,11e,15z)-1,19-dihydroxy-5-[(1e,3e)-6-hydroxy-3,5-dimethylhepta-1,3-dien-1-yl]-6,16,20-trimethoxy-2,10,14-trimethyl-4,21-dioxabicyclo[15.3.1]henicosa-9,11,15-trien-3-one

C34H54O9 (606.3768)

(2s,3r,4s,5r)-2-{[(1s,3r,6s,8r,9s,11s,12s,15s,16r)-9-hydroxy-15-[(2r,4s)-4-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl]oxy}oxane-3,4,5-triol

C35H58O8 (606.4131)

(1r,2s,3ar,4s,5ar,6s,7s,8s,10ar,10bs)-8-(acetyloxy)-4,6-bis(butanoyloxy)-7-hydroxy-1-isopropyl-3a,5a,9-trimethyl-1h,2h,3h,4h,5h,6h,7h,8h,10ah,10bh-cyclohepta[e]inden-2-yl butanoate

C34H54O9 (606.3768)

(2s,3r,4s,5s)-2-{[(3r,4s,4ar,6as,6br,8ar,9s,10s,12ar,12br,14bs)-3,10-dihydroxy-9-(hydroxymethyl)-2,2,4a,6a,6b,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicen-4-yl]oxy}oxane-3,4,5-triol

C35H58O8 (606.4131)

2-[5,13-dihydroxy-7,14-dimethyl-11-methylidene-15-(14-methylpentadecan-2-yl)-2,8-dioxo-1-oxa-4,7,12-triazacyclopentadeca-4,9,12-trien-3-yl]-2-hydroxyethanimidic acid

C32H54N4O7 (606.3992)

(3s,3as,4s,5ar,5br,7ar,11ar,11br,13ar,13bs)-13-hydroxy-3-(2-hydroxypropan-2-yl)-5a,5b,8,8,11a,13b-hexamethyl-4-{[(2r,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}-tetradecahydro-1h-cyclopenta[a]chrysen-9-one

C35H58O8 (606.4131)

3-[(2r,3s,4r,6r)-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]-6-[(4e,6e)-8-[(1z)-2,4-dimethyldec-1-en-1-yl]-3,9-dihydroxy-2,6-dimethylnona-4,6-dien-2-yl]-4-hydroxypyran-2-one

C34H54O9 (606.3768)

1-({1-[2-(2-isopropyl-3-methoxy-5-oxo-2h-pyrrole-1-carbonyl)pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl}(methyl)carbamoyl)-2-methylpropyl 2-(dimethylamino)-4-methylpentanoate

C32H54N4O7 (606.3992)

2-[(3,4,10-trihydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicen-4a-yl)methoxy]oxane-3,4,5-triol

C35H58O8 (606.4131)

(1s)-1-{[(2s)-1-[(2s)-2-[(2s)-2-isopropyl-3-methoxy-5-oxo-2h-pyrrole-1-carbonyl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl](methyl)carbamoyl}-2-methylpropyl (2s)-2-(dimethylamino)-4-methylpentanoate

C32H54N4O7 (606.3992)

(2r,3r,4s,5r)-2-{[(3s,4r,4ar,6as,6br,8ar,10r,12ar,12br,14bs)-3,4,10-trihydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicen-4a-yl]methoxy}oxane-3,4,5-triol

C35H58O8 (606.4131)

(1r,3s,4r,5s)-3,4,5-trihydroxy-1-[2-(1,3-oxazol-5-ylmethyl)-1,3-oxazol-4-yl]hexyl henicosanoate

C34H58N2O7 (606.4244)

3-(acetyloxy)-6-[(acetyloxy)methyl]-5-hydroxy-2-(2,3,4-trihydroxybutoxy)oxan-4-yl hexadecanoate

C30H54O12 (606.3615)

2-[(9z)-5,13-dihydroxy-7,14-dimethyl-11-methylidene-15-(14-methylpentadecan-2-yl)-2,8-dioxo-1-oxa-4,7,12-triazacyclopentadeca-4,9,12-trien-3-yl]-2-hydroxyethanimidic acid

C32H54N4O7 (606.3992)

(2r)-2-[(3s,9e,14r,15r)-5,13-dihydroxy-7,14-dimethyl-11-methylidene-15-[(2r)-14-methylpentadecan-2-yl]-2,8-dioxo-1-oxa-4,7,12-triazacyclopentadeca-4,9,12-trien-3-yl]-2-hydroxyethanimidic acid

C32H54N4O7 (606.3992)

(1r,2s,3ar,4s,5ar,6s,7s,8s,10ar,10bs)-7-(acetyloxy)-4,6-bis(butanoyloxy)-8-hydroxy-1-isopropyl-3a,5a,9-trimethyl-1h,2h,3h,4h,5h,6h,7h,8h,10ah,10bh-cyclohepta[e]inden-2-yl butanoate

C34H54O9 (606.3768)

(2r,3r,4s,5s,6r)-2-{[(1r,3ar,5r,5ar,7s,9ar,9bs,11ar)-1-[(2r,3e,5s)-5-ethyl-6-methylhept-3-en-2-yl]-5,5a-dihydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,5h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H58O8 (606.4131)

2-({9-hydroxy-15-[4-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl}oxy)oxane-3,4,5-triol

C35H58O8 (606.4131)

3-[3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]-6-[8-(2,4-dimethyldec-1-en-1-yl)-3,9-dihydroxy-2,6-dimethylnona-4,6-dien-2-yl]-4-hydroxypyran-2-one

C34H54O9 (606.3768)

(1r,2s,3s,4r,5r,6r)-2,3,4,5-tetrahydroxy-6-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}cyclohexyl icosanoate

C31H58O11 (606.3979)

12-hydroxy-17-{6-hydroxy-2,2,6-trimethyl-3-[(3,4,5-trihydroxyoxan-2-yl)oxy]cyclohexyl}-2,6,10,15-tetramethylheptadeca-2,6,10,14-tetraenal

C35H58O8 (606.4131)

3-[(2s,3r,4s,6s)-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]-6-[(4e,6e)-8-[(1z)-2,4-dimethyldec-1-en-1-yl]-3,9-dihydroxy-2,6-dimethylnona-4,6-dien-2-yl]-4-hydroxypyran-2-one

C34H54O9 (606.3768)

(2s,3r,4s,5r)-2-{[(1r,9s,12r,14s,17r,22s)-2-hydroxy-22-(2-hydroxypropan-2-yl)-3,8,8,17-tetramethyl-23,24-dioxaheptacyclo[19.2.1.0¹,¹⁸.0³,¹⁷.0⁴,¹⁴.0⁷,¹².0¹²,¹⁴]tetracosan-9-yl]oxy}oxane-3,4,5-triol

C34H54O9 (606.3768)

(2r,3r,4s,5r)-2-{[(3r,4s,4ar,6as,6br,8ar,9s,10s,12ar,12br,14bs)-3,10-dihydroxy-9-(hydroxymethyl)-2,2,4a,6a,6b,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicen-4-yl]oxy}oxane-3,4,5-triol

C35H58O8 (606.4131)

(1s,2r,4as,4br,6ar,7r,8r,9r,10ar,10br)-1,8,9-trihydroxy-4',4',4a,4b,7,10a-hexamethyl-3,4,5,6,6a,8,9,10,10b,11-decahydro-1h-spiro[chrysene-2,1'-cyclopentan]-7-ylmethyl (2z)-3-(4-hydroxyphenyl)prop-2-enoate

C38H54O6 (606.392)

2-{[1-(5-ethyl-6-methylhept-3-en-2-yl)-5,5a-dihydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,5h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H58O8 (606.4131)

(2s)-2-[(1r,3r,6r,10s,11s,12r,14r)-10,12-dihydroxy-14-(hydroxymethyl)-3,10-dimethyltricyclo[9.3.0.0³,⁷]tetradec-7-en-6-yl]propyl (2s)-2-[(2r,3r,5r,6s)-2-hydroxy-3,5-dimethyl-6-[(2s)-3-oxopentan-2-yl]oxan-2-yl]propanoate

C35H58O8 (606.4131)

(1s,3r,4s,5s)-3,4,5-trihydroxy-1-[2-(1,3-oxazol-5-ylmethyl)-1,3-oxazol-4-yl]hexyl henicosanoate

C34H58N2O7 (606.4244)

(2s,3r,4s,5s)-2-{[(3r,4s,4ar,6as,6br,9s,10s,12ar,14bs)-3,10-dihydroxy-9-(hydroxymethyl)-2,2,4a,6a,6b,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicen-4-yl]oxy}oxane-3,4,5-triol

C35H58O8 (606.4131)

2-[(3s,14s,15s)-15-(hexadecan-2-yl)-5,13-dihydroxy-7,14-dimethyl-11-methylidene-2,8-dioxo-1-oxa-4,7,12-triazacyclopentadeca-4,9,12-trien-3-yl]-2-hydroxyethanimidic acid

C32H54N4O7 (606.3992)

1,19-dihydroxy-5-(6-hydroxy-3,5-dimethylhepta-1,3-dien-1-yl)-6,16,20-trimethoxy-2,10,14-trimethyl-4,21-dioxabicyclo[15.3.1]henicosa-9,11,15-trien-3-one

C34H54O9 (606.3768)

(1s,3ar,3br,5ar,7s,9ar,9br,11ar)-1-[(2s)-2-hydroxy-6-methylhept-5-en-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C39H58O5 (606.4284)

(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl (11z)-octadec-11-enoate

C30H54O12 (606.3615)

8-[(4-hydroxy-5,6-dimethyl-2-oxopyran-3-yl)methyl]-4,4,7a,11b-tetramethyl-9-methylidene-decahydronaphtho[2,1-b]oxepin-3-yl (2e,4e,6e)-8-methyldeca-2,4,6-trienoate

C38H54O6 (606.392)

(2s)-2-[(1r,3r,6r,10s,11s,12r,14r)-10,12-dihydroxy-14-(hydroxymethyl)-3,10-dimethyltricyclo[9.3.0.0³,⁷]tetradec-7-en-6-yl]propyl (2r)-2-[(2r,3r,5r,6s)-2-hydroxy-3,5-dimethyl-6-[(2s)-3-oxopentan-2-yl]oxan-2-yl]propanoate

C35H58O8 (606.4131)

(3s,6r,8s,11r,12s,15s,16r,19s,21r)-19-hydroxy-3,7,7,11,16,20,20-heptamethylpentacyclo[13.8.0.0³,¹².0⁶,¹¹.0¹⁶,²¹]tricos-1(23)-en-8-yl 3-(3,4-dihydroxyphenyl)propanoate

C39H58O5 (606.4284)

1-(2,7-dihydroxy-6-methylhept-5-en-2-yl)-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl 3-(4-hydroxyphenyl)prop-2-enoate

C39H58O5 (606.4284)

8-[(4-hydroxy-5,6-dimethyl-2-oxopyran-3-yl)methyl]-4,4,7a,11b-tetramethyl-9-methylidene-decahydronaphtho[2,1-b]oxepin-3-yl 8-methyldeca-2,4,6-trienoate

C38H54O6 (606.392)

1-(2-hydroxy-6-methylhept-5-en-2-yl)-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl 3-(3,4-dihydroxyphenyl)prop-2-enoate

C39H58O5 (606.4284)